Literature DB >> 24195020

Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Kim Traxinger1, Crystal Kelly, Brent A Johnson, Robert H Lyles, Jonathan D Glass.   

Abstract

Amyotrophic lateral sclerosis is a disease with highly variable clinical features and prognosis. We analyzed the prognostic indicators of age, sex, bulbar or spinal onset, body mass index (BMI), and forced vital capacity (FVC) for 728 deceased patients from the Emory ALS Clinic. The median overall survival was 29.8 months from symptom onset, 15.8 months from diagnosis, and 14.3 months from the initial clinic visit. While univariate analyses revealed that each of the identified clinical features was strongly associated with patient survival, in multivariable analyses only age, BMI, and FVC measured at the first clinic visit were independent prognostic indicators; bulbar onset and sex were not significantly associated with survival prognosis after adjustment for the other clinical features.

Entities:  

Year:  2013        PMID: 24195020      PMCID: PMC3787117          DOI: 10.1212/CPJ.0b013e3182a1b8ab

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  19 in total

1.  Prognosis in amyotrophic lateral sclerosis: a population-based study.

Authors:  Adriano Chiò; Roberto Mutani; Gabriele Mora
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

2.  [The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments].

Authors:  F H Norris; E H Denys; K Sang; E Mukai
Journal:  Rinsho Shinkeigaku       Date:  1989-12

3.  Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Authors:  Adam Czaplinski; Albert A Yen; Stanley H Appel
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

4.  Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.

Authors:  Adriano Chiò; Andrea Calvo; Cristina Moglia; Letizia Mazzini; Gabriele Mora
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-03-14       Impact factor: 10.154

5.  Prognostic factors and survival in amyotrophic lateral sclerosis.

Authors:  O B Tysnes; S E Vollset; J P Larsen; J A Aarli
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

Review 6.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 7.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues.

Authors:  G Logroscino; B J Traynor; O Hardiman; A Chio'; P Couratier; J D Mitchell; R J Swingler; E Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01       Impact factor: 10.154

8.  Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study.

Authors:  K Murros; R Fogelholm
Journal:  Acta Neurol Scand       Date:  1983-01       Impact factor: 3.209

9.  Prognosis of amyotrophic lateral sclerosis and the effect of referral selection.

Authors:  J R Lee; J F Annegers; S H Appel
Journal:  J Neurol Sci       Date:  1995-10       Impact factor: 3.181

10.  Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001.

Authors:  Kazushi Okamoto; Gen Kobashi; Masakazu Washio; Satoshi Sasaki; Tetsuji Yokoyama; Yoshihiro Miyake; Naomasa Sakamoto; Heizo Tanaka; Yutaka Inaba
Journal:  J Epidemiol       Date:  2005-01       Impact factor: 3.211

View more
  45 in total

Review 1.  Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; April L McVey; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Head injury does not alter disease progression or neuropathologic outcomes in ALS.

Authors:  Christina N Fournier; Marla Gearing; Saila R Upadhyayula; Mitch Klein; Jonathan D Glass
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

3.  Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.

Authors:  Daniela Mariosa; John D Beard; David M Umbach; Rino Bellocco; Jean Keller; Tracy L Peters; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Fang Fang; Freya Kamel
Journal:  Am J Epidemiol       Date:  2017-03-01       Impact factor: 4.897

Review 4.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

5.  Factors predicting survival in ALS: a multicenter Italian study.

Authors:  Andrea Calvo; Cristina Moglia; Christian Lunetta; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialo; Gianni Sorarù; Francesca Trojsi; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Adriano Chiò; Valeria Ada Sansone; Gabriele Mora; Vincenzo Silani; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Maria Rosaria Monsurrò; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Nicola Fini; Jessica Mandrioli
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

6.  Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.

Authors:  Jeffrey M Statland; Dan Moore; Yunxia Wang; Maureen Walsh; Tahseen Mozaffar; Lauren Elman; Sharon P Nations; Hiroshi Mitsumoto; J Americo Fernandes; David Saperstein; Ghazala Hayat; Laura Herbelin; Chafic Karam; Jonathan Katz; Heather M Wilkins; Abdulbaki Agbas; Russell H Swerdlow; Regina M Santella; Mazen M Dimachkie; Richard J Barohn
Journal:  Muscle Nerve       Date:  2018-11-26       Impact factor: 3.217

7.  Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population.

Authors:  Mfon E Umoh; Christina Fournier; Yingjie Li; Meraida Polak; Latoya Shaw; John E Landers; William Hu; Marla Gearing; Jonathan D Glass
Journal:  Neurology       Date:  2016-08-03       Impact factor: 9.910

8.  Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Theodore Hyman; Amy Shui; Peggy Allred; Matthew Harms; Jingxia Liu; Nicholas Maragakis; David Schoenfeld; Hong Yu; Nazem Atassi; Merit Cudkowicz; Timothy M Miller
Journal:  Muscle Nerve       Date:  2015-06-01       Impact factor: 3.217

9.  Direct estimation for adaptive treatment length policies: Methods and application to evaluating the effect of delayed PEG insertion.

Authors:  Xin Lu; Brent A Johnson
Journal:  Biometrics       Date:  2016-12-23       Impact factor: 2.571

10.  Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Authors:  Angela Rosenbohm; Mingsheng Liu; Gabriele Nagel; Raphael S Peter; Bo Cui; Xiaoguang Li; Jan Kassubek; Dietrich Rothenbacher; Dorothée Lulé; Liying Cui; Albert C Ludolph
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.